finafloxacin
finafloxacin is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including XTORO. Available dosage form: suspension.
Drug Details
- Generic Name
- finafloxacin
- Brand Names
- XTORO
- Application Number
- NDA206307
- Sponsor
- Fonseca Biosciences, LLC
- NDC Codes
- 1
- Dosage Forms
- SUSPENSION
- Routes
- AURICULAR (OTIC)
- Active Ingredients
- FINAFLOXACIN
Indications and Usage
1 INDICATIONS AND USAGE XTORO® is indicated for the treatment of acute otitis externa (AOE) with or without an otowick, caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus in patients age 1 year and older. XTORO® is a quinolone antimicrobial indicated for the treatment of acute otitis externa (AOE) caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus . ( 1 )